MedPath

Vanderbilt University

Vanderbilt University logo
🇺🇸United States
Ownership
Private
Established
1873-01-01
Employees
10K
Market Cap
-
Website
http://www.vanderbilt.edu

Clinical Trials

518

Active:18
Completed:372

Trial Phases

6 Phases

Early Phase 1:10
Phase 1:49
Phase 2:48
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (392 trials with phase data)• Click on a phase to view related trials

Not Applicable
238 (60.7%)
Phase 1
49 (12.5%)
Phase 2
48 (12.2%)
Phase 4
34 (8.7%)
Phase 3
13 (3.3%)
Early Phase 1
10 (2.6%)

Project PAIR: Parent-implemented Articulation Intervention With Recast

Not Applicable
Recruiting
Conditions
Hearing Impaired Children
First Posted Date
2025-04-20
Last Posted Date
2025-06-29
Lead Sponsor
Vanderbilt University
Target Recruit Count
10
Registration Number
NCT06936696
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Sentence Shaping - DHH

Not Applicable
Not yet recruiting
Conditions
Hearing Loss, Bilateral
First Posted Date
2025-03-05
Last Posted Date
2025-06-08
Lead Sponsor
Vanderbilt University
Target Recruit Count
30
Registration Number
NCT06860022
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Evaluation of MBCT Implemented in Vietnamese Buddhist Pagoda

Not Applicable
Not yet recruiting
Conditions
Depressive Symptoms
Quality of Life
First Posted Date
2024-09-19
Last Posted Date
2025-06-24
Lead Sponsor
Vanderbilt University
Target Recruit Count
160
Registration Number
NCT06598579
Locations
🇻🇳

VNU University of Education, Hanoi, Vietnam

A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).

Not Applicable
Recruiting
Conditions
Prevention
Control
First Posted Date
2024-07-29
Last Posted Date
2024-08-09
Lead Sponsor
Vanderbilt University
Target Recruit Count
360
Registration Number
NCT06526052
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Northwestern University, Evanston, Illinois, United States

🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes

Not Applicable
Not yet recruiting
Conditions
PreDiabetes
Diet, Healthy
Nutritional and Metabolic Diseases
First Posted Date
2024-07-01
Last Posted Date
2025-04-27
Lead Sponsor
Vanderbilt University
Target Recruit Count
30
Registration Number
NCT06482944
Locations
🇺🇸

Vanderbilt University School of Nursing, Nashville, Tennessee, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 104
  • Next

News

Abvance Therapeutics Presents First Human Data on Fixed-Ratio Insulin-Glucagon Combination for Type 1 Diabetes

Abvance Therapeutics presented the first human clinical data evaluating fixed-ratio co-administration of insulin and glucagon at mealtime in Type 1 diabetes patients at the 85th ADA Scientific Sessions.

Nanobody Platform Enhances Cancer Immunotherapy Through Albumin Hitchhiking and STING Activation

Vanderbilt researchers developed albumin-hitchhiking nanobodies that extend circulation time from 5 minutes to 55 hours and achieve 11% injected dose per gram tumor accumulation.

VU319 Shows Promise in Phase 1 Trial for Alzheimer's Disease

VU319, an M1 positive allosteric modulator, has demonstrated encouraging results in a Phase 1 clinical trial for Alzheimer's disease and other neurodegenerative conditions.

© Copyright 2025. All Rights Reserved by MedPath